Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119694662 | 11969466 | 2 | F | 20131114 | 20160829 | 20160128 | 20160902 | EXP | GB-DRREDDYS-GER/UKI/16/0065440 | DR REDDYS | 77.00 | YR | M | Y | 105.20000 | KG | 20160902 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119694662 | 11969466 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | U | UNKNOWN | 76692 | 5 | MG | QD | |||||||
| 119694662 | 11969466 | 2 | SS | BISOPROLOL | BISOPROLOL | 1 | U | 0 | 5 | MG | QD | ||||||||
| 119694662 | 11969466 | 3 | SS | ENALAPRIL | ENALAPRIL | 1 | U | 0 | 10 | MG | QD | ||||||||
| 119694662 | 11969466 | 4 | SS | ETANERCEPT | ETANERCEPT | 1 | 1750 | MG | U | 0 | 50 | MG | /wk | ||||||
| 119694662 | 11969466 | 5 | SS | NOVOMIX | INSULIN ASPART | 1 | U | 0 | SUSPENSION FOR INJECTION | ||||||||||
| 119694662 | 11969466 | 6 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 0 | 20 | MG | QD | |||||||||
| 119694662 | 11969466 | 7 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | 0 | 4 | MG | QD | |||||||||
| 119694662 | 11969466 | 8 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | 500 | MG | BID | |||||||||
| 119694662 | 11969466 | 9 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119694662 | 11969466 | 1 | Hypertension |
| 119694662 | 11969466 | 2 | Hypertension |
| 119694662 | 11969466 | 3 | Hypertension |
| 119694662 | 11969466 | 4 | Product used for unknown indication |
| 119694662 | 11969466 | 5 | Type 2 diabetes mellitus |
| 119694662 | 11969466 | 6 | Depression |
| 119694662 | 11969466 | 7 | Hypertension |
| 119694662 | 11969466 | 8 | Type 2 diabetes mellitus |
| 119694662 | 11969466 | 9 | Hypercholesterolaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119694662 | 11969466 | HO |
| 119694662 | 11969466 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119694662 | 11969466 | Cholelithiasis | |
| 119694662 | 11969466 | Lumbar vertebral fracture | |
| 119694662 | 11969466 | Myocardial infarction | |
| 119694662 | 11969466 | Pulmonary hypertension | |
| 119694662 | 11969466 | Renal cyst | |
| 119694662 | 11969466 | Syncope | |
| 119694662 | 11969466 | Wound infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119694662 | 11969466 | 4 | 20130314 | 20131114 | 0 |